palbociclib
pfizer
[]
results so far: far and away people are voting they won't start new pts on palbo for cdk4/6. minority saying it doesn't influence their assessment of palbo activity. and, an even tinier minority saying the would consider switching people off palbo. #asco22 
Med Onc, Director of Breast & GYN Research Program @ Sarah Cannon Research Institute #bcsm #gyncsm #WomenInMedicine USAF Wife, Mom to 2 girls, tweets are mine.